Doctors test virus that targets pancreatic tumors
NCT ID NCT06693986
Summary
This early-stage study is testing a modified virus designed to infect and destroy pancreatic cancer cells when injected directly into tumors. Researchers are looking for the highest safe dose in 18 patients whose cancer is still confined to the pancreas area. The virus is delivered through an endoscopic tube to target the tumor specifically while minimizing effects on healthy tissue.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADENOCARCINOMA OF PANCREAS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Masonic Cancer Center
RECRUITINGMinneapolis, Minnesota, 55455, United States
Contact Phone: •••-•••-••••
Conditions
Explore the condition pages connected to this study.